Education
About Us
Working with TipRanks
Follow Us
Alcidion Group Limited (AU:ALC)
ASX:ALC
ALC Stock Chart & Stats
AU$0.10
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.10
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.15
Previous CloseN/A
Volume609.88K
Average Volume (3M)796.98K
Market Cap
AU$134.30M
Enterprise ValueAU$118.00M
Total Cash (Recent Filing)AU$17.70M
Total Debt (Recent Filing)AU$1.41M
Price to Earnings (P/E)83.3
Beta1.24
Next Earnings
Feb 25, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,342,952,600
10 Day Avg. Volume536,053
30 Day Avg. Volume796,979
Financial Highlights & Ratios
PEG Ratio-0.70
Price to Book (P/B)1.57
Price to Sales (P/S)3.38
P/FCF Ratio24.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.15Price Target Upside46.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelAlcidion’s subscription and licensing model creates durable, contractually-backed recurring revenue tied to hospital software use. That structure improves revenue visibility, supports multi-year customer relationships, and makes expansion and renewals high-leverage drivers of long-term cash flow and valuation resilience.
High Gross Margins And Revenue GrowthDouble-digit revenue growth combined with very high gross margins reflects a scalable software business with low incremental delivery costs. This margin profile supports reinvestment in product development and sales, enabling sustained organic growth and protecting profitability through operating leverage over multiple quarters.
Low Leverage And Strong Cash GenerationExtremely low debt and a dramatic improvement in free cash flow signal strong financial flexibility. Robust FCF conversion gives management optionality to fund deployments, M&A or product investment without leaning on external financing, lowering structural liquidity and refinancing risks over the medium term.
Bears Say
Negative EBIT MarginA negative EBIT margin shows core operating expenses still exceed operating profits, implying the business has not fully scaled operational cost bases against revenue. If persistent, this weakens sustainable operating profitability and constrains the ability to consistently convert top-line growth into durable operating earnings.
Thin Net ProfitabilityA low net margin limits retained earnings and reinvestment capacity, making long-term R&D and sales expansion more dependent on careful cash management. Even with high gross margins, thin net profitability leaves less buffer for unexpected contract losses or longer sales cycles common in healthcare procurement.
Concentrated Geographic/customer ExposureConcentration in a few national healthcare markets and reliance on hospital/health authority contracts exposes Alcidion to local budget cycles, procurement timelines and regulatory differences. This can slow global scale-up and makes revenue more sensitive to public healthcare spending shifts and long selling cycles.
Alcidion Group Limited News
ALC FAQ
What was Alcidion Group Limited’s price range in the past 12 months?
Alcidion Group Limited lowest share price was AU$0.06 and its highest was AU$0.14 in the past 12 months.
What is Alcidion Group Limited’s market cap?
Alcidion Group Limited’s market cap is AU$134.30M.
When is Alcidion Group Limited’s upcoming earnings report date?
Alcidion Group Limited’s upcoming earnings report date is Feb 25, 2026 which is in 9 days.
How were Alcidion Group Limited’s earnings last quarter?
Alcidion Group Limited released its earnings results on Aug 27, 2025. The company reported AU$0.002 earnings per share for the quarter, the consensus estimate of AU$0.002 by AU$0.
Is Alcidion Group Limited overvalued?
According to Wall Street analysts Alcidion Group Limited’s price is currently Undervalued.
Does Alcidion Group Limited pay dividends?
Alcidion Group Limited does not currently pay dividends.
What is Alcidion Group Limited’s EPS estimate?
Alcidion Group Limited’s EPS estimate is 0.
How many shares outstanding does Alcidion Group Limited have?
Alcidion Group Limited has 1,342,952,600 shares outstanding.
What happened to Alcidion Group Limited’s price movement after its last earnings report?
Alcidion Group Limited reported an EPS of AU$0.002 in its last earnings report, expectations of AU$0.002. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alcidion Group Limited?
Currently, no hedge funds are holding shares in AU:ALC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alcidion Group Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.15 (46.67% Upside)
AU$0.15 (46.67% Upside)
Blogger Sentiment
Bullish
AU:ALC Sentiment 95%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.66%
12-Months-Change
Fundamentals
Return on Equity
1.89%
Trailing 12-Months
Asset Growth
1.02%
Trailing 12-Months
Company Description
Alcidion Group Limited
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.
ALC Stock 12 Month Forecast
Average Price Target
AU$0.15
▲(46.67% Upside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Singular Health Group Ltd
―
PainChek Ltd
―
Options Prices
Currently, No data available
---